ewopharma: Recherche

1. À propos d'Ewopharma

… NOTRE STRATÉGIE TERRITOIRE NOS VALEURS RESPONSABILITÉ SOCIALE VISION/MISSION LEADERSHIP À propos d'Ewopharma Ewopharma est la société qui a succédé à MR Leclerc & Cie, fondée en 1959. Depuis le début, nous…

2. Ewopharma launches new Corporate Design

… Schaffhausen, 12th April 2019 – Getting 60 years in 2019 Ewopharma decided for a new appearance. The adjustments that have been made are a cautious and contemporary development – an evolution not a revolution. The new…

3. Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

… Schaffhausen, Switzerland, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of…

4. Amikin® - Ewopharma va distribuer un antibiotique essentiel en Suisse

… Schaffhouse, le 29 juillet 2019 – Ewopharma et Vianex S.A. sont heureux d’annoncer leur nouvelle collaboration pour la distribution d’Amikin® (amikacine) en Suisse. Ewopharma sera le nouveau titulaire de l’autorisation…

5. Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma

… diseases, today announced it has signed an exclusive distribution agreement with Switzerland-based Ewopharma for Piclidenoson in the treatment of psoriasis and Namodenoson in the treatment of liver diseases…

6. Ewopharma strengthens its oncology business

… Schaffhausen, 22nd June 2017: Ewopharma, a pharmaceutical marketing company and Eisai Co., Ltd. (TYO: 4523), a leading global research and development-based pharmaceutical company are pleased to announce that as of 1st…

7. Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS)

… someone else. To learn more please check: www.proibs.eu. Calmino group AB (Gothenburg, Sweden) and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the…

8. Ewopharma and Eisai announce Commercial Partnership in Central Eastern Europe for Lenvima® (lenvatinib)

… SCHAFFHAUSEN, SWITZERLAND and HATFIELD, UK, 26th March, 2020 – Ewopharma, a pharmaceutical marketing company and Eisai Europe Ltd., a leading global research and development-based pharmaceutical company are pleased to…

9. Shield Therapeutics and ewopharma sign Feraccru licence agreement for Switzerland

… Therapeutics plc (LSE:STX), a speciality pharmaceutical company focused on secondary care, and Ewopharma AG, a pharmaceutical marketing company headquartered in Schaffhausen, Switzerland, are pleased to…

10. Otsuka and Ewopharma join the fight against tuberculosis in Romania by launching Deltyba®

… Otsuka and Ewopharma AG join the fight against tuberculosis in Romania by launching Otsuka’s orphan drug Deltyba® (delamanid) for multidrug-resistant tuberculosis SCHAFFHAUSEN, 20th January 2020 - Tuberculosis…